Correction: VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR–PI3K–AKT pathway (Oncogene, (2018), 37, 41, (5585-5586), 10.1038/s41388-018-0495-6)

D. Elias; Henriette Vever; A. V. Lænkholm; M. F. Gjerstorff; C. W. Yde; A. E. Lykkesfeldt; H. J. Ditzel

doi:10.1038/s41388-019-1096-8

Correction: VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR–PI3K–AKT pathway (Oncogene, (2018), 37, 41, (5585-5586), 10.1038/s41388-018-0495-6)

D. Elias^*, Henriette Vever, A. V. Lænkholm, M. F. Gjerstorff, C. W. Yde, A. E. Lykkesfeldt, H. J. Ditzel

^*Kontaktforfatter

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

26 Downloads (Pure)

Abstrakt

Since the publication of this Erratum, the Authors noticed a further error in Fig. 1c. The same image was inserted twice next to each other (second row: PRKCA, image for RamR7 and TamR8) instead of the correct image for TamR8. The corrected Fig. 1c has been provided below.

Originalsprog	Engelsk
Tidsskrift	Oncogene
Vol/bind	39
Udgave nummer	10
Sider (fra-til)	2229-2230
ISSN	0950-9232
DOI	https://doi.org/10.1038/s41388-019-1096-8
Status	Udgivet - mar. 2020

Dokumenter og links

10.1038/s41388-019-1096-8Licens: CC BY

Open Access VersionForlagets udgivne version, 1,16 MBLicens: CC BY

Fingeraftryk

Dyk ned i forskningsemnerne om 'Correction: VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR–PI3K–AKT pathway (Oncogene, (2018), 37, 41, (5585-5586), 10.1038/s41388-018-0495-6)'. Sammen danner de et unikt fingeraftryk.

1 Tidsskriftartikel
1 Kommentar/debat

Correction to: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy (Oncogene, (2015), 34, 15, (1919-1927), 10.1038/onc.2014.138)
Elias, D., Vever, H., Lænkholm, A. V., Gjerstorff, M. F., Yde, C. W., Lykkesfeldt, A. E. & Ditzel, H. J., okt. 2018, I: Oncogene. 37, 41, s. 5585–5586
Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

Åben adgang
Fil
115 Downloads (Pure)
Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy
Elias, D., (Hansen) Vever, H., Lænkholm, A-V., Gjerstorff, M. F., Yde, C. W., Lykkesfeldt, A. E. & Ditzel, H. J., 9. apr. 2015, I: Oncogene. 34, s. 1919–1927
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Citationsformater

Elias, D., Vever, H., Lænkholm, A. V., Gjerstorff, M. F., Yde, C. W., Lykkesfeldt, A. E., & Ditzel, H. J. (2020). Correction: VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR–PI3K–AKT pathway (Oncogene, (2018), 37, 41, (5585-5586), 10.1038/s41388-018-0495-6). Oncogene, 39(10), 2229-2230. https://doi.org/10.1038/s41388-019-1096-8

@article{8901d82f074d4db38c9f9a5aeb62c298,

title = "Correction: VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR–PI3K–AKT pathway (Oncogene, (2018), 37, 41, (5585-5586), 10.1038/s41388-018-0495-6)",

abstract = "Since the publication of this Erratum, the Authors noticed a further error in Fig. 1c. The same image was inserted twice next to each other (second row: PRKCA, image for RamR7 and TamR8) instead of the correct image for TamR8. The corrected Fig. 1c has been provided below.",

author = "D. Elias and Henriette Vever and L{\ae}nkholm, {A. V.} and Gjerstorff, {M. F.} and Yde, {C. W.} and Lykkesfeldt, {A. E.} and Ditzel, {H. J.}",

year = "2020",

month = mar,

doi = "10.1038/s41388-019-1096-8",

language = "English",

volume = "39",

pages = "2229--2230",

journal = "Oncogene",

issn = "0950-9232",

publisher = "Nature Publishing Group",

number = "10",

}

Elias, D, Vever, H, Lænkholm, AV, Gjerstorff, MF, Yde, CW, Lykkesfeldt, AE & Ditzel, HJ 2020, 'Correction: VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR–PI3K–AKT pathway (Oncogene, (2018), 37, 41, (5585-5586), 10.1038/s41388-018-0495-6)', Oncogene, bind 39, nr. 10, s. 2229-2230. https://doi.org/10.1038/s41388-019-1096-8

Correction : VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR–PI3K–AKT pathway (Oncogene, (2018), 37, 41, (5585-5586), 10.1038/s41388-018-0495-6). / Elias, D.; Vever, Henriette; Lænkholm, A. V. et al.

I: Oncogene, Bind 39, Nr. 10, 03.2020, s. 2229-2230.

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

TY - JOUR

T1 - Correction

T2 - VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR–PI3K–AKT pathway (Oncogene, (2018), 37, 41, (5585-5586), 10.1038/s41388-018-0495-6)

AU - Elias, D.

AU - Vever, Henriette

AU - Lænkholm, A. V.

AU - Gjerstorff, M. F.

AU - Yde, C. W.

AU - Lykkesfeldt, A. E.

AU - Ditzel, H. J.

PY - 2020/3

Y1 - 2020/3

N2 - Since the publication of this Erratum, the Authors noticed a further error in Fig. 1c. The same image was inserted twice next to each other (second row: PRKCA, image for RamR7 and TamR8) instead of the correct image for TamR8. The corrected Fig. 1c has been provided below.

AB - Since the publication of this Erratum, the Authors noticed a further error in Fig. 1c. The same image was inserted twice next to each other (second row: PRKCA, image for RamR7 and TamR8) instead of the correct image for TamR8. The corrected Fig. 1c has been provided below.

U2 - 10.1038/s41388-019-1096-8

DO - 10.1038/s41388-019-1096-8

M3 - Comment/debate

C2 - 31712727

VL - 39

SP - 2229

EP - 2230

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 10

ER -

Correction: VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR–PI3K–AKT pathway (Oncogene, (2018), 37, 41, (5585-5586), 10.1038/s41388-018-0495-6)

Abstrakt

Dokumenter og links

Fingeraftryk

Relaterede publikationer

Correction to: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy (Oncogene, (2015), 34, 15, (1919-1927), 10.1038/onc.2014.138)

Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

Citationsformater